Efficacy of immune checkpoint inhibitors for in-transit melanoma

Efficacy of immune checkpoint inhibitors for in-transit melanoma

Background The efficacy of immune checkpoint inhibitors (ICI) in metastatic melanoma is well established. However, there are limited data regarding their efficacy in in-transit melanoma (ITM). This study assessed the efficacy of ICI in patients with ITM.Methods A retrospective review of patients wit...

Full description

Bibliographic Details
Main Authors: Victoria Atkinson, Shahneen Sandhu, Georgina V Long, David E Gyorki, George Au-Yeung, Grant A McArthur, Euan Walpole, Mark Smithers, Alexander Menzies, Robyn Saw, Tavis Read, Julia Lai-Kwon, Lumine Na, Emilia Nan Tie, Michael Alexander Rtshiladze, James Bozzi
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/1/e000440.full

Internet

https://jitc.bmj.com/content/8/1/e000440.full

Similar Items